Overview

• Australia’s regulator approved Kisunla to treat early-stage Alzheimer’s, though experts warn just 10–20% of patients will qualify and face an estimated $80,000 treatment cost.
• Dr Johannes Uys highlights that motor changes—such as unsteady gait, clumsiness, coordination problems and limb stiffness—can precede memory loss in dementia.
• According to neurologist Dr Tim Rittman, persistent low mood and increased anxiety are often among the first cognitive symptoms signalling dementia risk.
• Surveys indicate that only one in three people seek medical advice within a month of noticing symptoms, despite early diagnosis being crucial for managing decline.
• A new analysis of half a million UK Biobank records finds that individuals at higher genetic risk for Alzheimer’s may display increased social engagement in preclinical stages.